These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 15492840)
1. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Singal R; Ferdinand L; Das PM; Reis IM; Schlesselman JJ Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840 [TBL] [Abstract][Full Text] [Related]
2. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study. Safarinejad MR; Shafiei N; Safarinejad S Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317 [TBL] [Abstract][Full Text] [Related]
3. [The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer]. Si PR; Fang DC; Zhang H; Yang LQ; Luo YH; Liao HY Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Oct; 26(10):794-9. PubMed ID: 16536307 [TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Marchal C; Redondo M; Reyes-Engel A; Perea-Milla E; Gaitan MJ; Machuca J; Diaz F; Caballero J; Carnero J Eur J Surg Oncol; 2008 Jul; 34(7):805-10. PubMed ID: 17967524 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Kim JK; Kim S; Han JH; Kim HJ; Chong SY; Hong SP; Hwang SG; Ahn JY; Cha KY; Oh D; Kim NK Anticancer Res; 2005; 25(3B):2249-52. PubMed ID: 16158971 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Shen H; Spitz MR; Wang LE; Hong WK; Wei Q Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):397-401. PubMed ID: 11319182 [TBL] [Abstract][Full Text] [Related]
7. [Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer]. Wang L; Lin DX; Lu XH; Miao XP; Li H Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):50-4. PubMed ID: 16737574 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Shi Q; Zhang Z; Li G; Pillow PC; Hernandez LM; Spitz MR; Wei Q Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1477-84. PubMed ID: 15941959 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985 [TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men. Safarinejad MR; Shafiei N; Safarinejad S Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764 [TBL] [Abstract][Full Text] [Related]
12. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842 [TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Matsuo K; Hamajima N; Suzuki R; Ogura M; Kagami Y; Taji H; Yasue T; Mueller NE; Nakamura S; Seto M; Morishima Y; Tajima K Am J Hematol; 2004 Dec; 77(4):351-7. PubMed ID: 15551285 [TBL] [Abstract][Full Text] [Related]
14. Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Jiang Q; Chen K; Ma X; Li Q; Yu W; Shu G; Yao K Cancer Detect Prev; 2005; 29(2):146-54. PubMed ID: 15829374 [TBL] [Abstract][Full Text] [Related]
15. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Le Marchand L; Haiman CA; Wilkens LR; Kolonel LN; Henderson BE Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763 [TBL] [Abstract][Full Text] [Related]
16. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cicek MS; Nock NL; Li L; Conti DV; Casey G; Witte JS Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1331-6. PubMed ID: 15298954 [TBL] [Abstract][Full Text] [Related]
17. [Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer]. Zhang XM; Miao XP; Tan W; Qu SN; Sun T; Zhou YF; Lin DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):700-3. PubMed ID: 16447641 [TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Robien K; Ulrich CM; Bigler J; Yasui Y; Gooley T; Bruemmer B; Potter JD; Radich JP Clin Cancer Res; 2004 Nov; 10(22):7592-8. PubMed ID: 15569990 [TBL] [Abstract][Full Text] [Related]
19. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia. Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH; Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089 [TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]